FDA authorises first point-of-care (POC) antibody test for COVID-19

FDA has reissued an emergency use authorization for the Assure COVID-19 IgG/IgM Rapid Test Device using fingerstick blood samples, which can now be tested in doctor's offices, hospitals, urgent care centres and emergency departments rather than having to be sent to a central lab.

Source:

Biospace Inc.